These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
406 related articles for article (PubMed ID: 17599739)
81. Early BAFF receptor blockade mitigates murine Sjögren's syndrome: Concomitant targeting of CXCL13 and the BAFF receptor prevents salivary hypofunction. Sharma A; Kiripolsky J; Klimatcheva E; Howell A; Fereidouni F; Levenson R; Rothstein TL; Kramer JM Clin Immunol; 2016 Mar; 164():85-94. PubMed ID: 26826598 [TBL] [Abstract][Full Text] [Related]
82. Interleukin-6 inhibits apoptosis of exocrine gland tissues under inflammatory conditions. Zhou J; Jin JO; Patel ES; Yu Q Cytokine; 2015 Dec; 76(2):244-252. PubMed ID: 26255211 [TBL] [Abstract][Full Text] [Related]
83. Metformin improves salivary gland inflammation and hypofunction in murine Sjögren's syndrome. Kim JW; Kim SM; Park JS; Hwang SH; Choi J; Jung KA; Ryu JG; Lee SY; Kwok SK; Cho ML; Park SH Arthritis Res Ther; 2019 Jun; 21(1):136. PubMed ID: 31164166 [TBL] [Abstract][Full Text] [Related]
84. Immunohistopathology of Sjögren's syndrome. Konttinen YT; Porola P; Konttinen L; Laine M; Poduval P Autoimmun Rev; 2006 Nov; 6(1):16-20. PubMed ID: 17110311 [TBL] [Abstract][Full Text] [Related]
85. Suppression of streptococcal cell wall-induced arthritis by human chorionic gonadotropin. Song XY; Zeng L; Jin W; Pilo CM; Frank ME; Wahl SM Arthritis Rheum; 2000 Sep; 43(9):2064-72. PubMed ID: 11014358 [TBL] [Abstract][Full Text] [Related]
86. [Effect of topical injection of cyclosporine A on saliva secretion and inflammation in the submandibular gland of non-obese diabetic mice]. Zhu YY; Min SN; Yu GY Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Aug; 53(4):750-757. PubMed ID: 34393240 [TBL] [Abstract][Full Text] [Related]
87. Effects of total glucosides of paeony for delaying onset of Sjogren's syndrome: an animal study. Li CL; He J; Li ZG; Zheng LW; Hua H J Craniomaxillofac Surg; 2013 Oct; 41(7):610-5. PubMed ID: 23333492 [TBL] [Abstract][Full Text] [Related]
88. New concepts for the development of autoimmune exocrinopathy derived from studies with the NOD mouse model. Humphreys-Beher MG; Peck AB Arch Oral Biol; 1999 May; 44 Suppl 1():S21-5. PubMed ID: 10414851 [TBL] [Abstract][Full Text] [Related]
89. Analysis of transforming growth factor beta and other cytokines in autoimmune exocrinopathy (Sjögren's syndrome). Ogawa N; Dang H; Lazaridis K; McGuff HS; Aufdemorte TB; Talal N J Interferon Cytokine Res; 1995 Sep; 15(9):759-67. PubMed ID: 8536103 [TBL] [Abstract][Full Text] [Related]
90. Aberrant proteolytic digestion of biglycan and decorin by saliva and exocrine gland lysates from the NOD mouse model for autoimmune exocrinopathy. Yamachika S; Brayer J; Oxford GE; Peck AB; Humphreys-Beher MG Clin Exp Rheumatol; 2000; 18(2):233-40. PubMed ID: 10812497 [TBL] [Abstract][Full Text] [Related]
91. Temporal changes in salivary glands of non-obese diabetic mice as a model for Sjögren's syndrome. Roescher N; Lodde BM; Vosters JL; Tak PP; Catalan MA; Illei GG; Chiorini JA Oral Dis; 2012 Jan; 18(1):96-106. PubMed ID: 21914088 [TBL] [Abstract][Full Text] [Related]
92. Abnormal basement membrane type IV collagen alpha-chain composition in labial salivary glands in Sjögren's syndrome. Poduval P; Sillat T; Virtanen I; Porola P; Konttinen YT Arthritis Rheum; 2009 Apr; 60(4):938-45. PubMed ID: 19333954 [TBL] [Abstract][Full Text] [Related]
93. Activation of TLR9-dependent p38MAPK pathway in the pathogenesis of primary Sjögren's syndrome in NOD/Ltj mouse. Shi H; Yu CQ; Xie LS; Wang ZJ; Zhang P; Zheng LY J Oral Pathol Med; 2014 Nov; 43(10):785-91. PubMed ID: 25065264 [TBL] [Abstract][Full Text] [Related]
94. Salivary gland epithelial cells: a new source of the immunoregulatory hormone adiponectin. Katsiougiannis S; Kapsogeorgou EK; Manoussakis MN; Skopouli FN Arthritis Rheum; 2006 Jul; 54(7):2295-9. PubMed ID: 16802369 [TBL] [Abstract][Full Text] [Related]
95. Agonist-induced 4-1BB activation prevents the development of Sjӧgren's syndrome-like sialadenitis in non-obese diabetic mice. Zhou J; You BR; Yu Q Biochim Biophys Acta Mol Basis Dis; 2020 Mar; 1866(3):165605. PubMed ID: 31740402 [TBL] [Abstract][Full Text] [Related]
96. Overexpression of phosphorylated STAT-1alpha in the labial salivary glands of patients with Sjögren's syndrome. Wakamatsu E; Matsumoto I; Yasukochi T; Naito Y; Goto D; Mamura M; Ito S; Tsutsumi A; Sumida T Arthritis Rheum; 2006 Nov; 54(11):3476-84. PubMed ID: 17075845 [TBL] [Abstract][Full Text] [Related]
98. Green tea polyphenols reduce autoimmune symptoms in a murine model for human Sjogren's syndrome and protect human salivary acinar cells from TNF-alpha-induced cytotoxicity. Hsu SD; Dickinson DP; Qin H; Borke J; Ogbureke KU; Winger JN; Camba AM; Bollag WB; Stöppler HJ; Sharawy MM; Schuster GS Autoimmunity; 2007 Mar; 40(2):138-47. PubMed ID: 17364504 [TBL] [Abstract][Full Text] [Related]
99. Improvement of lacrimal function by topical application of CyA in murine models of Sjögren's syndrome. Tsubota K; Fujita H; Tadano K; Takeuchi T; Murakami T; Saito I; Hayashi Y Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):101-10. PubMed ID: 11133854 [TBL] [Abstract][Full Text] [Related]
100. Effects of oral consumption of the green tea polyphenol EGCG in a murine model for human Sjogren's syndrome, an autoimmune disease. Gillespie K; Kodani I; Dickinson DP; Ogbureke KU; Camba AM; Wu M; Looney S; Chu TC; Qin H; Bisch F; Sharawy M; Schuster GS; Hsu SD Life Sci; 2008 Oct; 83(17-18):581-8. PubMed ID: 18809413 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]